Diagnostic Identifies Squamous Lung Cancer With 96% Sensitivity
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read MorePosted by Clinical Lab Products | Mar 13, 2009 | Cancer, Miscellaneous |
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read MorePosted by Clinical Lab Products | Mar 3, 2009 | Cancer, Miscellaneous |
Genentech Inc on Monday touted its culture of innovative research and offered detailed long-term sales projections as it made its case to Wall Street on what it considers a low buyout bid from drug maker Roche.
Read MorePosted by Clinical Lab Products | Mar 2, 2009 | Cancer, Miscellaneous |
CombiMatrix Corp announces positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it can non-invasively screen for the early detection of cancer.
Read MorePosted by Clinical Lab Products | Feb 24, 2009 | Cancer, Miscellaneous |
Testing of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine.
Read MorePosted by Clinical Lab Products | Feb 12, 2009 | Cancer, Miscellaneous |
ViraCor Laboratories announces the launch of a new cytomegalovirus (CMV) antiviral resistance test that provides diagnosis days faster than other tests on the market.
Read More